Human Metabolome Technologies, Inc.
FY ending June 2027 First Quarter Financial Summary [Japanese GAAP] (Consolidated)
Net sales were 253,163 thousand yen, up 31.6% year-over-year. Operating loss was 4,709 thousand yen, ordinary loss was 687 thousand yen, and quarterly net loss attributable to owners of the parent was 3,233 thousand yen. Full-year forecasts remain unchanged. Treasury stock did not remain unchanged; net assets decreased due to recording the quarterly net loss.
Key Figures
- Net Sales: 253,163 thousand yen
- Operating Loss: -4,709 thousand yen
- Ordinary Loss: -687 thousand yen
- Quarterly Net Loss Attributable to Owners of Parent: -3,233 thousand yen
- Quarterly Net Loss per Share: -0.59 yen
AI要約
Performance Overview
For the quarter, net sales were 253,163 thousand yen (up 31.6% year-over-year), demonstrating steady growth. Operating loss was 4,709 thousand yen, ordinary loss was 687 thousand yen, and quarterly net loss attributable to owners of the parent was 3,233 thousand yen. Gross profit was 162,890 thousand yen, supported by a decrease in cost of sales and an increase in backlog. The full-year earnings forecast remains unchanged from the previous announcement.
Financial Position, Cash Position and Dividends
Total assets were 1,974,259 thousand yen and net assets were 1,700,630 thousand yen. Treasury stock was 375,923 thousand yen (at fiscal year-end), and dividends remain undisclosed as in the prior year. Cash and deposits decreased significantly; current assets were 1,424,133 thousand yen and current liabilities were 260,989 thousand yen. Attention is required regarding the decline in net assets and the status of treasury stock holdings.
Human Metabolome Technologies, Inc.
Company overview · Stock price · Financial data · All IR
